Dr. Valery Feigin is a world-renowned neuroscientist and leading authority in stroke epidemiology and prevention. He currently serves as Professor of Neurology and Epidemiology and Director of the National Institute for Stroke and Applied Neurosciences at Auckland University of Technology in New Zealand. With an extensive international academic presence, he also holds positions as Affiliate Professor at the University of Washington, Visiting Professor at Capital Medical University of China, and Honorary Professor at Novosibirsk State Medical University in Russia. His distinguished career began with medical training at Novosibirsk Medical University in Russia followed by advanced specialization in neurology and clinical epidemiology at the prestigious Mayo Clinic in the United States and Erasmus University in the Netherlands. Dr. Feigin's leadership extends across multiple continents, reflecting his significant influence in global neurological health research.
Dr. Feigin's groundbreaking research has fundamentally transformed our understanding of stroke epidemiology and prevention strategies worldwide. His work has been recognized by Web of Science as placing him annually among the top 1% most cited scientists globally since 2018, with an impressive citation count exceeding 348,000 and an h-index of 137 as of August 2024. A major contribution to the field is his development of the Stroke RiskometerTM App, endorsed by the World Stroke Organization and other international neurological bodies, which provides accessible stroke risk assessment to millions globally. This innovative tool has catalyzed a paradigm shift in stroke prevention approaches, enabling large-scale epidemiological studies that significantly advance our knowledge of non-communicable diseases worldwide. His research has established new standards for measuring and addressing the global burden of stroke and traumatic brain injury through comprehensive epidemiological frameworks.
Beyond his research achievements, Dr. Feigin has been instrumental in shaping global neurological health policy as Editor-in-Chief of the journal Neuroepidemiology and Co-Chair of the Global Policy Committee of the World Stroke Organization. He serves as Chairman of the Neurology Section of the Global Burden of Disease study and leads the Stroke and TBI Expert Panels, coordinating international research efforts across numerous institutions. As a Fellow of the Royal Society of New Zealand, American Academy of Neurology, and Russian Academy of Sciences, his contributions have earned him the highest professional recognition in multiple countries. Dr. Feigin continues to drive innovation in neurological health through international collaborative studies that promise to further illuminate the complex determinants of stroke and other non-communicable diseases, ensuring his work maintains significant impact on global healthcare strategies for years to come.
